Literature DB >> 25332610

Eosinophilic vasculitis: time for recognition of a new entity?

Arjun Datt Law1, Subhash Varma1, Neelam Varma2, Alka Khadwal1, Gaurav Prakash1, Vikas Suri1, Savita Kumari1, Pankaj Malhotra1.   

Abstract

Hypereosinophilia is part of a group of complex disorders with multisystem involvement. A 23 year old male was admitted to our centre with bilateral popliteal artery and venous thrombosis and impending gangrene of the left forefoot along with deep venous thrombosis of the right lower extremity. Investigations revealed marked peripheral blood eosinophilia (27,669/μL). Bone marrow showed increased eosinophils & eosinophil precursors and no evidence of a clonal disorder. Skin biopsy from the ulcerated lesions showed small vessel vasculitis with intense eosinophilic infiltration. Investigations to look for secondary causes of hypereosinophilia in the form of Antinuclear Antibody, P-Anti Neutrophil Cytoplasmic Antibody (ANCA) and C-ANCA and FIP1L1-PDGFRA, Bcr-Abl and JAK2V617F mutations were negative. The arterial and venous thrombosis and cutaneous vasculitis were linked to the presence of hypereosinophilic syndrome. The patient's illness responded to high dose corticosteroids leading to complete resolution of symptoms. We reviewed the literature on the lesser known entity of eosinophilic vasculitis and its association with thrombosis.

Entities:  

Keywords:  Eosinophilia; Thrombosis; Vasculitis

Year:  2014        PMID: 25332610      PMCID: PMC4192264          DOI: 10.1007/s12288-014-0384-2

Source DB:  PubMed          Journal:  Indian J Hematol Blood Transfus        ISSN: 0971-4502            Impact factor:   0.900


  26 in total

Review 1.  Imatinib mesylate for the treatment of hypereosinophilic syndromes.

Authors:  Sabina A Antoniu
Journal:  Curr Opin Investig Drugs       Date:  2006-11

Review 2.  Association of cutaneous necrotizing eosinophilic vasculitis and deep vein thrombosis in hypereosinophilic syndrome.

Authors:  Yi-Hua Liao; Yi-Wen Su; Woei Tsay; Hsien-Ching Chiu
Journal:  Arch Dermatol       Date:  2005-08

3.  Cytotoxic properties of the eosinophil major basic protein.

Authors:  G J Gleich; E Frigas; D A Loegering; D L Wassom; D Steinmuller
Journal:  J Immunol       Date:  1979-12       Impact factor: 5.422

4.  Contemporary consensus proposal on criteria and classification of eosinophilic disorders and related syndromes.

Authors:  Peter Valent; Amy D Klion; Hans-Peter Horny; Florence Roufosse; Jason Gotlib; Peter F Weller; Andrzej Hellmann; Georgia Metzgeroth; Kristin M Leiferman; Michel Arock; Joseph H Butterfield; Wolfgang R Sperr; Karl Sotlar; Peter Vandenberghe; Torsten Haferlach; Hans-Uwe Simon; Andreas Reiter; Gerald J Gleich
Journal:  J Allergy Clin Immunol       Date:  2012-03-28       Impact factor: 10.793

5.  Eosinophilic vasculitis: an inhabitual and resistant manifestation of a vasculitis.

Authors:  P Jandus; N Bianda; M Alerci; A Gallino; C Marone
Journal:  Vasa       Date:  2010-11       Impact factor: 1.961

6.  Cerebral sinovenous thrombosis in the idiopathic hypereosinophilic syndrome in childhood.

Authors:  H Schulman; L Hertzog; H Zirkin; Y Hertzanu
Journal:  Pediatr Radiol       Date:  1999-08

7.  Acute pulmonary embolism in a patient with hypereosinophilia and psoriasis.

Authors:  Jui-Hung Ko; Jheng-Wei Lin; Rosaline Chung-Yee Hui
Journal:  Chang Gung Med J       Date:  2011

8.  Haemorrhagic stroke and vasculitic-like cerebral angiography in a patient with eosinophilic fasciitis. Case report.

Authors:  P C Cecchi; P Caramaschi; G Pinna; A Schwarz; A Bricolo
Journal:  J Neurosurg Sci       Date:  2006-12       Impact factor: 2.279

9.  Long-term safety of mepolizumab for the treatment of hypereosinophilic syndromes.

Authors:  Florence E Roufosse; Jean-Emmanuel Kahn; Gerald J Gleich; Lawrence B Schwartz; Anish D Singh; Lanny J Rosenwasser; Judah A Denburg; Johannes Ring; Marc E Rothenberg; Javed Sheikh; Ann E Haig; Stephen A Mallett; Deborah N Templeton; Hector G Ortega; Amy D Klion
Journal:  J Allergy Clin Immunol       Date:  2012-10-04       Impact factor: 10.793

10.  Characterization of molecular interactions between eosinophil cationic protein and heparin.

Authors:  Tan-chi Fan; Shun-lung Fang; Chi-shin Hwang; Chih-yen Hsu; Xin-an Lu; Shang-cheng Hung; Shu-Chuan Lin; Margaret Dah-Tsyr Chang
Journal:  J Biol Chem       Date:  2008-06-30       Impact factor: 5.157

View more
  3 in total

1.  Hypereosinophilia in a Young Patient: Occam's Razor or Hickam's Dictum?

Authors:  Arjun Lakshman; Ram V Nampoothiri; Arjun Datt Law; Pankaj Malhotra; Subhash C Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2014-12-24       Impact factor: 0.900

2.  Finger necrosis with eosinophilia and symmetrical occlusion of the peripheral artery.

Authors:  Ryo Nishikawa; Toru Hirano; Osami Kawarada
Journal:  Heart Asia       Date:  2019-06-05

3.  Hypereosinophilic vasculitis: A case report.

Authors:  Husam Alzayer; Manal Ahmed Hasan
Journal:  Medicine (Baltimore)       Date:  2019-04       Impact factor: 1.817

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.